J Y Cahn Selected Research

J Y Cahn Research Topics

Disease

7	Lymphoma (Lymphomas) 01/2020 - 05/2000
5	Neoplasms (Cancer) 11/2017 - 02/2000
5	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2012 - 02/2000
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2003 - 05/2000
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2017 - 12/2000
4	Acute Promyelocytic Leukemia 02/2005 - 06/2000
4	Leukemia 01/2001 - 02/2000
3	Bronchiolitis Obliterans Syndrome 05/2003 - 02/2000
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 04/2002
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2017 - 01/2000
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2014 - 11/2013
2	Herpes Simplex 01/2001 - 02/2000
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2016
1	Aspergillosis 10/2012
1	Diarrhea 10/2012
1	Large Granular Lymphocytic Leukemia 09/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2012
1	Multiple Myeloma 01/2005
1	Breast Neoplasms (Breast Cancer) 06/2003
1	Disease Progression 04/2003
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2003
1	Cardiotoxicity 02/2003
1	Polyarteritis Nodosa (Periarteritis Nodosa) 05/2002
1	Burkitt Lymphoma (Burkitt's Lymphoma) 09/2001
1	Hemolysis 09/2001
1	Chronic Hepatitis C 07/2001
1	Chronic Hepatitis (Chronic Active Hepatitis) 07/2001
1	Hematologic Neoplasms (Hematological Malignancy) 01/2001
1	Sarcoma (Soft Tissue Sarcoma) 07/2000
1	Hodgkin Disease (Hodgkin's Disease) 07/2000
1	Infections 06/2000
1	Vitiligo 02/2000
1	Fanconi Anemia (Fanconi's Anemia) 01/2000

Drug/Important Bio-Agent (IBA)

3	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2005 - 06/2000
3	Thymidine KinaseIBA 01/2001 - 02/2000
3	Ganciclovir (Cytovene)FDA LinkGeneric 01/2001 - 02/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2004 - 03/2001
2	Proteins (Proteins, Gene)FDA Link 04/2002 - 09/2001
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2001 - 06/2000
1	Lenalidomide (CC 5013)FDA Link 05/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2017
1	posaconazole FDA Link 10/2012
1	TriazolesIBA 10/2012
1	Antifungal AgentsIBA 10/2012
1	Thalidomide (Thalomid)FDA Link 01/2005
1	Etoposide (VP 16)FDA LinkGeneric 06/2003
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 06/2003
1	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2003
1	AnthracyclinesIBA 06/2003
1	Dihydrotachysterol (AT 10)IBA 04/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2003
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2002
1	Cyclin BIBA 04/2002
1	SurvivinIBA 04/2002
1	Interferon-alpha (Interferon Alfa)IBA 07/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2001
1	DioxinsIBA 07/2000
1	Solid WasteIBA 07/2000
1	AntibodiesIBA 06/2000
1	LenograstimIBA 02/2000
1	Blood Group Antigens (Blood Groups)IBA 01/2000
1	Busulfan (Busulfex)FDA Link 01/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2000

Therapy/Procedure

11	Transplantation 01/2020 - 01/2000
10	Stem Cell Transplantation 01/2020 - 01/2000
6	Therapeutics 01/2020 - 06/2000
4	Drug Therapy (Chemotherapy) 02/2005 - 05/2000
3	Hematopoietic Stem Cell Transplantation 01/2020 - 12/2000
2	Salvage Therapy 01/2005 - 01/2005
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2001 - 02/2000
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2001 - 12/2000
1	Immunomodulation 03/2016
1	Photopheresis 09/2012
1	Radiotherapy 06/2003
1	VAP-cyclo protocol 02/2003
1	Plasmapheresis 05/2002
1	Remission Induction 03/2001
1	Homologous Transplantation 02/2000